Specific codes in ICD-10 are unique alphanumeric designations used to identify and categorize diseases, disorders, and conditions. They consist of 3-5 characters, including both letters and numbers, that provide a high level of detail and specificity.
| Language | Translation |
|---|---|
English
|
Soft tissue disorders related to use, overuse and pressure |
French
|
Affections des tissus mous par sollicitation excessive de l'articulation |
| Level | Code | Title | |
|---|---|---|---|
| 1 | XIII | Diseases of the musculoskeletal system and connective tissue | |
| 2 | M60-M79 | Soft tissue disorders | |
| 3 | M70-M79 | Other soft tissue disorders | |
| 4 | M70 | Soft tissue disorders related to use, overuse and pressure |
| Code | Title | |
|---|---|---|
| M70.0 | Chronic crepitant synovitis of hand and wrist | |
| M70.1 | Bursitis of hand | |
| M70.2 | Olecranon bursitis | |
| M70.3 | Other bursitis of elbow | |
| M70.4 | Prepatellar bursitis | |
| M70.5 | Other bursitis of knee | |
| M70.6 | Trochanteric bursitis | |
| M70.7 | Other bursitis of hip | |
| M70.8 | Other soft tissue disorders related to use, overuse and pressure | |
| M70.9 | Unspecified soft tissue disorder related to use, overuse and pressure |
| Active Ingredient | Description | |
|---|---|---|
| Betamethasone |
Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties. |
|
| Diclofenac |
Diclofenac is a non-steroidal anti-inflammatory drug. The mechanism of action of diclofenac in AK may be related to the inhibition of the cycloxygenase pathway leading to reduced prostaglandin E2 (PGE2) synthesis. In addition, immunohistochemistry (IHC) from skin biopsies ac revealed that the clinical effects of diclofenac in AK are primarily due to anti-inflammatory, anti-angiogenic and possibly anti-proliferative effects and apoptosis-inducing mechanisms. |
|
| Etofenamate |
Etofenamate is a flufenamic acid derivative, which is readily transported through the skin and concentrated in inflamed tissue, where it exerts anti-inflammatory and analgesic effects by inhibiting the release of histamine, lysosomal enzymes and prostaglandin. |
|
| Flurbiprofen |
Flurbiprofen is a propionic acid derivative NSAID which acts through inhibition of prostaglandin synthesis. In humans flurbiprofen has potent analgesic, antipyretic and anti-inflammatory properties. |
|
| Hydrocortisone |
Hydrocortisone is the main glucocorticoid secreted by the adrenal cortex. Hydrocortisone is an anti-inflammatory steroid. Its anti-inflammatory action is due to reduction in the vascular component of the inflammatory response and reduction in the formation of inflammatory fluid and cellular exudates. |
|
| Nimesulide |
Nimesulide is a non-steroidal anti-inflammatory drug with analgesic and antipyretic properties which acts as an inhibitor of prostaglandin synthesis enzyme cyclo-oxygenase. Cyclo-oxygenase produces prostaglandins, some of them being implicated in the development and maintenance of inflammation. |
|
| Triamcinolone |
Triamcinolone acetonide is a more potent derivative of triamcinolone and is approximately 8 times more potent than prednisone. Although the precise mechanism of corticosteroid anti-allergic action is unknown, corticosteroids are very effective in the treatment of allergic diseases in man. Also, local injections are thought to have an anti-inflammatory effect. |
